nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—MPO—Carboplatin—testicular cancer	0.195	0.322	CbGbCtD
Melatonin—MPO—Cisplatin—testicular cancer	0.167	0.275	CbGbCtD
Melatonin—CYP1B1—Doxorubicin—testicular cancer	0.0744	0.123	CbGbCtD
Melatonin—CYP2C19—Ifosfamide—testicular cancer	0.0485	0.0799	CbGbCtD
Melatonin—CYP2C9—Ifosfamide—testicular cancer	0.0403	0.0665	CbGbCtD
Melatonin—SLC22A8—Methotrexate—testicular cancer	0.0398	0.0656	CbGbCtD
Melatonin—CYP1A2—Etoposide—testicular cancer	0.0214	0.0352	CbGbCtD
Melatonin—CYP19A1—corpus luteum—testicular cancer	0.0208	0.127	CbGeAlD
Melatonin—CYP2C9—Cisplatin—testicular cancer	0.0196	0.0323	CbGbCtD
Melatonin—CYP19A1—seminiferous tubule of testis—testicular cancer	0.0177	0.108	CbGeAlD
Melatonin—CYP19A1—semen—testicular cancer	0.00976	0.0595	CbGeAlD
Melatonin—CALM2—semen—testicular cancer	0.00843	0.0514	CbGeAlD
Melatonin—CALM1—semen—testicular cancer	0.00839	0.0511	CbGeAlD
Melatonin—ASMT—gonad—testicular cancer	0.00786	0.0479	CbGeAlD
Melatonin—CALR—embryo—testicular cancer	0.00621	0.0378	CbGeAlD
Melatonin—CALR—seminal vesicle—testicular cancer	0.00583	0.0355	CbGeAlD
Melatonin—ASMT—testis—testicular cancer	0.00567	0.0345	CbGeAlD
Melatonin—MTNR1A—testis—testicular cancer	0.0046	0.028	CbGeAlD
Melatonin—CALR—gonad—testicular cancer	0.00421	0.0257	CbGeAlD
Melatonin—MT3—testis—testicular cancer	0.00385	0.0235	CbGeAlD
Melatonin—IDO1—lymph node—testicular cancer	0.00376	0.0229	CbGeAlD
Melatonin—CALR—female gonad—testicular cancer	0.00343	0.0209	CbGeAlD
Melatonin—NQO2—seminal vesicle—testicular cancer	0.00329	0.02	CbGeAlD
Melatonin—CALR—testis—testicular cancer	0.00304	0.0185	CbGeAlD
Melatonin—MT3—lymph node—testicular cancer	0.00279	0.017	CbGeAlD
Melatonin—CALM3—seminal vesicle—testicular cancer	0.00228	0.0139	CbGeAlD
Melatonin—CALR—lymph node—testicular cancer	0.0022	0.0134	CbGeAlD
Melatonin—NQO2—female gonad—testicular cancer	0.00193	0.0118	CbGeAlD
Melatonin—ESR1—embryo—testicular cancer	0.00191	0.0117	CbGeAlD
Melatonin—CALM2—embryo—testicular cancer	0.0019	0.0116	CbGeAlD
Melatonin—CALM1—embryo—testicular cancer	0.00189	0.0115	CbGeAlD
Melatonin—CALM2—seminal vesicle—testicular cancer	0.00179	0.0109	CbGeAlD
Melatonin—NQO2—testis—testicular cancer	0.00171	0.0104	CbGeAlD
Melatonin—CYP19A1—gonad—testicular cancer	0.0015	0.00911	CbGeAlD
Melatonin—CYP1B1—gonad—testicular cancer	0.0014	0.00852	CbGeAlD
Melatonin—CALM3—female gonad—testicular cancer	0.00134	0.00814	CbGeAlD
Melatonin—MPO—testis—testicular cancer	0.00132	0.00804	CbGeAlD
Melatonin—ESR1—gonad—testicular cancer	0.0013	0.00792	CbGeAlD
Melatonin—CALM2—gonad—testicular cancer	0.00129	0.00787	CbGeAlD
Melatonin—CALM1—gonad—testicular cancer	0.00129	0.00783	CbGeAlD
Melatonin—NQO2—lymph node—testicular cancer	0.00124	0.00757	CbGeAlD
Melatonin—CYP19A1—female gonad—testicular cancer	0.00122	0.0074	CbGeAlD
Melatonin—CALM3—testis—testicular cancer	0.00119	0.00722	CbGeAlD
Melatonin—CYP1B1—female gonad—testicular cancer	0.00114	0.00692	CbGeAlD
Melatonin—CYP19A1—testis—testicular cancer	0.00108	0.00657	CbGeAlD
Melatonin—ESR1—female gonad—testicular cancer	0.00106	0.00643	CbGeAlD
Melatonin—CALM2—female gonad—testicular cancer	0.00105	0.0064	CbGeAlD
Melatonin—CALM1—female gonad—testicular cancer	0.00104	0.00637	CbGeAlD
Melatonin—CYP1B1—testis—testicular cancer	0.00101	0.00614	CbGeAlD
Melatonin—MPO—lymph node—testicular cancer	0.000956	0.00582	CbGeAlD
Melatonin—ESR1—testis—testicular cancer	0.000937	0.00571	CbGeAlD
Melatonin—CALM2—testis—testicular cancer	0.000931	0.00567	CbGeAlD
Melatonin—CALM1—testis—testicular cancer	0.000927	0.00565	CbGeAlD
Melatonin—CALM3—lymph node—testicular cancer	0.000859	0.00524	CbGeAlD
Melatonin—CYP1A1—female gonad—testicular cancer	0.000803	0.00489	CbGeAlD
Melatonin—CYP19A1—lymph node—testicular cancer	0.000781	0.00476	CbGeAlD
Melatonin—CYP1B1—lymph node—testicular cancer	0.00073	0.00445	CbGeAlD
Melatonin—ESR1—lymph node—testicular cancer	0.000679	0.00414	CbGeAlD
Melatonin—CALM2—lymph node—testicular cancer	0.000675	0.00411	CbGeAlD
Melatonin—CALM1—lymph node—testicular cancer	0.000672	0.00409	CbGeAlD
Melatonin—CYP1A1—lymph node—testicular cancer	0.000516	0.00315	CbGeAlD
Melatonin—Breast disorder—Methotrexate—testicular cancer	0.000354	0.00206	CcSEcCtD
Melatonin—Vertigo—Etoposide—testicular cancer	0.000354	0.00206	CcSEcCtD
Melatonin—Headache—Vinblastine—testicular cancer	0.000354	0.00206	CcSEcCtD
Melatonin—Leukopenia—Etoposide—testicular cancer	0.000353	0.00205	CcSEcCtD
Melatonin—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000352	0.00205	CcSEcCtD
Melatonin—Abdominal pain—Dactinomycin—testicular cancer	0.000351	0.00205	CcSEcCtD
Melatonin—Fatigue—Ifosfamide—testicular cancer	0.000351	0.00204	CcSEcCtD
Melatonin—Hypersensitivity—Bleomycin—testicular cancer	0.000351	0.00204	CcSEcCtD
Melatonin—Infection—Cisplatin—testicular cancer	0.000349	0.00203	CcSEcCtD
Melatonin—Pain—Ifosfamide—testicular cancer	0.000348	0.00203	CcSEcCtD
Melatonin—Mood swings—Epirubicin—testicular cancer	0.000348	0.00202	CcSEcCtD
Melatonin—Loss of consciousness—Etoposide—testicular cancer	0.000347	0.00202	CcSEcCtD
Melatonin—Lethargy—Doxorubicin—testicular cancer	0.000347	0.00202	CcSEcCtD
Melatonin—Nervous system disorder—Cisplatin—testicular cancer	0.000344	0.002	CcSEcCtD
Melatonin—Thrombocytopenia—Cisplatin—testicular cancer	0.000344	0.002	CcSEcCtD
Melatonin—Asthenia—Bleomycin—testicular cancer	0.000342	0.00199	CcSEcCtD
Melatonin—Skin disorder—Cisplatin—testicular cancer	0.000341	0.00199	CcSEcCtD
Melatonin—Hyponatraemia—Doxorubicin—testicular cancer	0.000341	0.00198	CcSEcCtD
Melatonin—Hypertension—Etoposide—testicular cancer	0.00034	0.00198	CcSEcCtD
Melatonin—Pain in extremity—Doxorubicin—testicular cancer	0.00034	0.00198	CcSEcCtD
Melatonin—Liver function test abnormal—Epirubicin—testicular cancer	0.000339	0.00197	CcSEcCtD
Melatonin—Pruritus—Bleomycin—testicular cancer	0.000337	0.00196	CcSEcCtD
Melatonin—Dry skin—Epirubicin—testicular cancer	0.000336	0.00196	CcSEcCtD
Melatonin—Chest pain—Etoposide—testicular cancer	0.000336	0.00195	CcSEcCtD
Melatonin—Nausea—Vinblastine—testicular cancer	0.000335	0.00195	CcSEcCtD
Melatonin—Abdominal pain upper—Epirubicin—testicular cancer	0.000335	0.00195	CcSEcCtD
Melatonin—Affect lability—Doxorubicin—testicular cancer	0.000334	0.00195	CcSEcCtD
Melatonin—Migraine—Doxorubicin—testicular cancer	0.000334	0.00195	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000333	0.00194	CcSEcCtD
Melatonin—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000333	0.00194	CcSEcCtD
Melatonin—Breast disorder—Epirubicin—testicular cancer	0.000332	0.00193	CcSEcCtD
Melatonin—Nasopharyngitis—Epirubicin—testicular cancer	0.000328	0.00191	CcSEcCtD
Melatonin—Hypersensitivity—Dactinomycin—testicular cancer	0.000328	0.00191	CcSEcCtD
Melatonin—Abdominal discomfort—Methotrexate—testicular cancer	0.000325	0.00189	CcSEcCtD
Melatonin—Gastritis—Epirubicin—testicular cancer	0.000325	0.00189	CcSEcCtD
Melatonin—Abdominal pain—Ifosfamide—testicular cancer	0.000322	0.00187	CcSEcCtD
Melatonin—Mood swings—Doxorubicin—testicular cancer	0.000322	0.00187	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00032	0.00186	CcSEcCtD
Melatonin—Infection—Etoposide—testicular cancer	0.00032	0.00186	CcSEcCtD
Melatonin—Asthenia—Dactinomycin—testicular cancer	0.000319	0.00186	CcSEcCtD
Melatonin—Paraesthesia—Cisplatin—testicular cancer	0.000315	0.00184	CcSEcCtD
Melatonin—Thrombocytopenia—Etoposide—testicular cancer	0.000315	0.00183	CcSEcCtD
Melatonin—Liver function test abnormal—Doxorubicin—testicular cancer	0.000313	0.00182	CcSEcCtD
Melatonin—Skin disorder—Etoposide—testicular cancer	0.000313	0.00182	CcSEcCtD
Melatonin—Dry skin—Doxorubicin—testicular cancer	0.000311	0.00181	CcSEcCtD
Melatonin—Abdominal pain upper—Doxorubicin—testicular cancer	0.00031	0.00181	CcSEcCtD
Melatonin—Angina pectoris—Epirubicin—testicular cancer	0.000309	0.0018	CcSEcCtD
Melatonin—Breast disorder—Doxorubicin—testicular cancer	0.000307	0.00179	CcSEcCtD
Melatonin—Nasopharyngitis—Doxorubicin—testicular cancer	0.000304	0.00177	CcSEcCtD
Melatonin—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000303	0.00176	CcSEcCtD
Melatonin—Vomiting—Bleomycin—testicular cancer	0.000303	0.00176	CcSEcCtD
Melatonin—Infestation—Methotrexate—testicular cancer	0.000302	0.00176	CcSEcCtD
Melatonin—Infestation NOS—Methotrexate—testicular cancer	0.000302	0.00176	CcSEcCtD
Melatonin—Rash—Bleomycin—testicular cancer	0.000301	0.00175	CcSEcCtD
Melatonin—Gastritis—Doxorubicin—testicular cancer	0.000301	0.00175	CcSEcCtD
Melatonin—Pain—Cisplatin—testicular cancer	0.0003	0.00175	CcSEcCtD
Melatonin—Dermatitis—Bleomycin—testicular cancer	0.0003	0.00175	CcSEcCtD
Melatonin—Hypersensitivity—Ifosfamide—testicular cancer	0.0003	0.00175	CcSEcCtD
Melatonin—Stomatitis—Methotrexate—testicular cancer	0.000295	0.00171	CcSEcCtD
Melatonin—Asthenia—Ifosfamide—testicular cancer	0.000292	0.0017	CcSEcCtD
Melatonin—Paraesthesia—Etoposide—testicular cancer	0.000289	0.00168	CcSEcCtD
Melatonin—Weight increased—Epirubicin—testicular cancer	0.000289	0.00168	CcSEcCtD
Melatonin—Pruritus—Ifosfamide—testicular cancer	0.000288	0.00168	CcSEcCtD
Melatonin—Haematuria—Methotrexate—testicular cancer	0.000288	0.00168	CcSEcCtD
Melatonin—Somnolence—Etoposide—testicular cancer	0.000286	0.00166	CcSEcCtD
Melatonin—Angina pectoris—Doxorubicin—testicular cancer	0.000286	0.00166	CcSEcCtD
Melatonin—Hepatobiliary disease—Methotrexate—testicular cancer	0.000286	0.00166	CcSEcCtD
Melatonin—Nausea—Bleomycin—testicular cancer	0.000283	0.00165	CcSEcCtD
Melatonin—Infestation NOS—Epirubicin—testicular cancer	0.000283	0.00165	CcSEcCtD
Melatonin—Infestation—Epirubicin—testicular cancer	0.000283	0.00165	CcSEcCtD
Melatonin—Vomiting—Dactinomycin—testicular cancer	0.000283	0.00165	CcSEcCtD
Melatonin—Rash—Dactinomycin—testicular cancer	0.00028	0.00163	CcSEcCtD
Melatonin—Gastrointestinal disorder—Etoposide—testicular cancer	0.000278	0.00162	CcSEcCtD
Melatonin—Fatigue—Etoposide—testicular cancer	0.000277	0.00161	CcSEcCtD
Melatonin—Stomatitis—Epirubicin—testicular cancer	0.000276	0.0016	CcSEcCtD
Melatonin—Pain—Etoposide—testicular cancer	0.000275	0.0016	CcSEcCtD
Melatonin—Haematuria—Epirubicin—testicular cancer	0.00027	0.00157	CcSEcCtD
Melatonin—Dizziness—Ifosfamide—testicular cancer	0.000269	0.00157	CcSEcCtD
Melatonin—Urinary tract disorder—Methotrexate—testicular cancer	0.000268	0.00156	CcSEcCtD
Melatonin—Hepatobiliary disease—Epirubicin—testicular cancer	0.000267	0.00156	CcSEcCtD
Melatonin—Weight increased—Doxorubicin—testicular cancer	0.000267	0.00155	CcSEcCtD
Melatonin—Urethral disorder—Methotrexate—testicular cancer	0.000266	0.00155	CcSEcCtD
Melatonin—Nausea—Dactinomycin—testicular cancer	0.000264	0.00154	CcSEcCtD
Melatonin—Gastrointestinal pain—Etoposide—testicular cancer	0.000263	0.00153	CcSEcCtD
Melatonin—Infestation NOS—Doxorubicin—testicular cancer	0.000262	0.00152	CcSEcCtD
Melatonin—Infestation—Doxorubicin—testicular cancer	0.000262	0.00152	CcSEcCtD
Melatonin—Vomiting—Ifosfamide—testicular cancer	0.000259	0.00151	CcSEcCtD
Melatonin—Hypersensitivity—Cisplatin—testicular cancer	0.000259	0.00151	CcSEcCtD
Melatonin—Rash—Ifosfamide—testicular cancer	0.000257	0.0015	CcSEcCtD
Melatonin—Dermatitis—Ifosfamide—testicular cancer	0.000257	0.00149	CcSEcCtD
Melatonin—Stomatitis—Doxorubicin—testicular cancer	0.000255	0.00148	CcSEcCtD
Melatonin—Abdominal pain—Etoposide—testicular cancer	0.000254	0.00148	CcSEcCtD
Melatonin—Eye disorder—Methotrexate—testicular cancer	0.000254	0.00148	CcSEcCtD
Melatonin—Asthenia—Cisplatin—testicular cancer	0.000252	0.00147	CcSEcCtD
Melatonin—Cardiac disorder—Methotrexate—testicular cancer	0.000252	0.00147	CcSEcCtD
Melatonin—Urinary tract disorder—Epirubicin—testicular cancer	0.000251	0.00146	CcSEcCtD
Melatonin—Haematuria—Doxorubicin—testicular cancer	0.000249	0.00145	CcSEcCtD
Melatonin—Connective tissue disorder—Epirubicin—testicular cancer	0.000249	0.00145	CcSEcCtD
Melatonin—Urethral disorder—Epirubicin—testicular cancer	0.000249	0.00145	CcSEcCtD
Melatonin—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000247	0.00144	CcSEcCtD
Melatonin—Angiopathy—Methotrexate—testicular cancer	0.000246	0.00143	CcSEcCtD
Melatonin—Immune system disorder—Methotrexate—testicular cancer	0.000245	0.00143	CcSEcCtD
Melatonin—Nausea—Ifosfamide—testicular cancer	0.000242	0.00141	CcSEcCtD
Melatonin—Mental disorder—Methotrexate—testicular cancer	0.000238	0.00138	CcSEcCtD
Melatonin—Eye disorder—Epirubicin—testicular cancer	0.000237	0.00138	CcSEcCtD
Melatonin—Hypersensitivity—Etoposide—testicular cancer	0.000237	0.00138	CcSEcCtD
Melatonin—Erythema—Methotrexate—testicular cancer	0.000236	0.00137	CcSEcCtD
Melatonin—Malnutrition—Methotrexate—testicular cancer	0.000236	0.00137	CcSEcCtD
Melatonin—Cardiac disorder—Epirubicin—testicular cancer	0.000236	0.00137	CcSEcCtD
Melatonin—Urinary tract disorder—Doxorubicin—testicular cancer	0.000232	0.00135	CcSEcCtD
Melatonin—Asthenia—Etoposide—testicular cancer	0.000231	0.00134	CcSEcCtD
Melatonin—Connective tissue disorder—Doxorubicin—testicular cancer	0.000231	0.00134	CcSEcCtD
Melatonin—Angiopathy—Epirubicin—testicular cancer	0.00023	0.00134	CcSEcCtD
Melatonin—Urethral disorder—Doxorubicin—testicular cancer	0.00023	0.00134	CcSEcCtD
Melatonin—Immune system disorder—Epirubicin—testicular cancer	0.000229	0.00133	CcSEcCtD
Melatonin—Back pain—Methotrexate—testicular cancer	0.000228	0.00133	CcSEcCtD
Melatonin—Pruritus—Etoposide—testicular cancer	0.000228	0.00133	CcSEcCtD
Melatonin—Vomiting—Cisplatin—testicular cancer	0.000223	0.0013	CcSEcCtD
Melatonin—Vision blurred—Methotrexate—testicular cancer	0.000223	0.0013	CcSEcCtD
Melatonin—Mental disorder—Epirubicin—testicular cancer	0.000222	0.00129	CcSEcCtD
Melatonin—Rash—Cisplatin—testicular cancer	0.000221	0.00129	CcSEcCtD
Melatonin—Dermatitis—Cisplatin—testicular cancer	0.000221	0.00129	CcSEcCtD
Melatonin—Malnutrition—Epirubicin—testicular cancer	0.000221	0.00129	CcSEcCtD
Melatonin—Erythema—Epirubicin—testicular cancer	0.000221	0.00129	CcSEcCtD
Melatonin—Eye disorder—Doxorubicin—testicular cancer	0.00022	0.00128	CcSEcCtD
Melatonin—Cardiac disorder—Doxorubicin—testicular cancer	0.000218	0.00127	CcSEcCtD
Melatonin—Flatulence—Epirubicin—testicular cancer	0.000218	0.00127	CcSEcCtD
Melatonin—Tension—Epirubicin—testicular cancer	0.000217	0.00126	CcSEcCtD
Melatonin—Nervousness—Epirubicin—testicular cancer	0.000215	0.00125	CcSEcCtD
Melatonin—Back pain—Epirubicin—testicular cancer	0.000214	0.00124	CcSEcCtD
Melatonin—Angiopathy—Doxorubicin—testicular cancer	0.000213	0.00124	CcSEcCtD
Melatonin—Dizziness—Etoposide—testicular cancer	0.000213	0.00124	CcSEcCtD
Melatonin—Muscle spasms—Epirubicin—testicular cancer	0.000212	0.00124	CcSEcCtD
Melatonin—Immune system disorder—Doxorubicin—testicular cancer	0.000212	0.00123	CcSEcCtD
Melatonin—Vertigo—Methotrexate—testicular cancer	0.000212	0.00123	CcSEcCtD
Melatonin—Leukopenia—Methotrexate—testicular cancer	0.000211	0.00123	CcSEcCtD
Melatonin—Nausea—Cisplatin—testicular cancer	0.000209	0.00121	CcSEcCtD
Melatonin—Vision blurred—Epirubicin—testicular cancer	0.000208	0.00121	CcSEcCtD
Melatonin—Mental disorder—Doxorubicin—testicular cancer	0.000206	0.0012	CcSEcCtD
Melatonin—Vomiting—Etoposide—testicular cancer	0.000205	0.00119	CcSEcCtD
Melatonin—Erythema—Doxorubicin—testicular cancer	0.000204	0.00119	CcSEcCtD
Melatonin—Malnutrition—Doxorubicin—testicular cancer	0.000204	0.00119	CcSEcCtD
Melatonin—Agitation—Epirubicin—testicular cancer	0.000203	0.00118	CcSEcCtD
Melatonin—Rash—Etoposide—testicular cancer	0.000203	0.00118	CcSEcCtD
Melatonin—Dermatitis—Etoposide—testicular cancer	0.000203	0.00118	CcSEcCtD
Melatonin—Headache—Etoposide—testicular cancer	0.000202	0.00117	CcSEcCtD
Melatonin—Flatulence—Doxorubicin—testicular cancer	0.000202	0.00117	CcSEcCtD
Melatonin—Arthralgia—Methotrexate—testicular cancer	0.000201	0.00117	CcSEcCtD
Melatonin—Chest pain—Methotrexate—testicular cancer	0.000201	0.00117	CcSEcCtD
Melatonin—Tension—Doxorubicin—testicular cancer	0.000201	0.00117	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.0002	0.00116	CcSEcCtD
Melatonin—Nervousness—Doxorubicin—testicular cancer	0.000199	0.00116	CcSEcCtD
Melatonin—Vertigo—Epirubicin—testicular cancer	0.000199	0.00116	CcSEcCtD
Melatonin—Syncope—Epirubicin—testicular cancer	0.000198	0.00115	CcSEcCtD
Melatonin—Leukopenia—Epirubicin—testicular cancer	0.000198	0.00115	CcSEcCtD
Melatonin—Back pain—Doxorubicin—testicular cancer	0.000198	0.00115	CcSEcCtD
Melatonin—Muscle spasms—Doxorubicin—testicular cancer	0.000197	0.00114	CcSEcCtD
Melatonin—Palpitations—Epirubicin—testicular cancer	0.000195	0.00114	CcSEcCtD
Melatonin—Loss of consciousness—Epirubicin—testicular cancer	0.000194	0.00113	CcSEcCtD
Melatonin—Vision blurred—Doxorubicin—testicular cancer	0.000193	0.00112	CcSEcCtD
Melatonin—Infection—Methotrexate—testicular cancer	0.000191	0.00111	CcSEcCtD
Melatonin—Nausea—Etoposide—testicular cancer	0.000191	0.00111	CcSEcCtD
Melatonin—Hypertension—Epirubicin—testicular cancer	0.000191	0.00111	CcSEcCtD
Melatonin—Nervous system disorder—Methotrexate—testicular cancer	0.000189	0.0011	CcSEcCtD
Melatonin—Thrombocytopenia—Methotrexate—testicular cancer	0.000189	0.0011	CcSEcCtD
Melatonin—Chest pain—Epirubicin—testicular cancer	0.000188	0.0011	CcSEcCtD
Melatonin—Arthralgia—Epirubicin—testicular cancer	0.000188	0.0011	CcSEcCtD
Melatonin—Agitation—Doxorubicin—testicular cancer	0.000188	0.00109	CcSEcCtD
Melatonin—Anxiety—Epirubicin—testicular cancer	0.000188	0.00109	CcSEcCtD
Melatonin—Skin disorder—Methotrexate—testicular cancer	0.000187	0.00109	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000187	0.00109	CcSEcCtD
Melatonin—Dry mouth—Epirubicin—testicular cancer	0.000184	0.00107	CcSEcCtD
Melatonin—Vertigo—Doxorubicin—testicular cancer	0.000184	0.00107	CcSEcCtD
Melatonin—Syncope—Doxorubicin—testicular cancer	0.000183	0.00107	CcSEcCtD
Melatonin—Leukopenia—Doxorubicin—testicular cancer	0.000183	0.00107	CcSEcCtD
Melatonin—Palpitations—Doxorubicin—testicular cancer	0.000181	0.00105	CcSEcCtD
Melatonin—Loss of consciousness—Doxorubicin—testicular cancer	0.00018	0.00105	CcSEcCtD
Melatonin—Infection—Epirubicin—testicular cancer	0.000179	0.00104	CcSEcCtD
Melatonin—Shock—Epirubicin—testicular cancer	0.000177	0.00103	CcSEcCtD
Melatonin—Nervous system disorder—Epirubicin—testicular cancer	0.000177	0.00103	CcSEcCtD
Melatonin—Thrombocytopenia—Epirubicin—testicular cancer	0.000177	0.00103	CcSEcCtD
Melatonin—Hypertension—Doxorubicin—testicular cancer	0.000177	0.00103	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000176	0.00102	CcSEcCtD
Melatonin—Skin disorder—Epirubicin—testicular cancer	0.000175	0.00102	CcSEcCtD
Melatonin—Insomnia—Methotrexate—testicular cancer	0.000174	0.00101	CcSEcCtD
Melatonin—Arthralgia—Doxorubicin—testicular cancer	0.000174	0.00101	CcSEcCtD
Melatonin—Chest pain—Doxorubicin—testicular cancer	0.000174	0.00101	CcSEcCtD
Melatonin—Anxiety—Doxorubicin—testicular cancer	0.000173	0.00101	CcSEcCtD
Melatonin—Paraesthesia—Methotrexate—testicular cancer	0.000173	0.00101	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000173	0.00101	CcSEcCtD
Melatonin—Somnolence—Methotrexate—testicular cancer	0.000171	0.000997	CcSEcCtD
Melatonin—Dry mouth—Doxorubicin—testicular cancer	0.00017	0.000991	CcSEcCtD
Melatonin—Dyspepsia—Methotrexate—testicular cancer	0.00017	0.000987	CcSEcCtD
Melatonin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000166	0.000968	CcSEcCtD
Melatonin—Fatigue—Methotrexate—testicular cancer	0.000166	0.000967	CcSEcCtD
Melatonin—Infection—Doxorubicin—testicular cancer	0.000166	0.000965	CcSEcCtD
Melatonin—Pain—Methotrexate—testicular cancer	0.000165	0.000959	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000164	0.000956	CcSEcCtD
Melatonin—Shock—Doxorubicin—testicular cancer	0.000164	0.000956	CcSEcCtD
Melatonin—Nervous system disorder—Doxorubicin—testicular cancer	0.000164	0.000953	CcSEcCtD
Melatonin—Thrombocytopenia—Doxorubicin—testicular cancer	0.000163	0.000951	CcSEcCtD
Melatonin—Insomnia—Epirubicin—testicular cancer	0.000163	0.00095	CcSEcCtD
Melatonin—Skin disorder—Doxorubicin—testicular cancer	0.000162	0.000944	CcSEcCtD
Melatonin—Paraesthesia—Epirubicin—testicular cancer	0.000162	0.000943	CcSEcCtD
Melatonin—Somnolence—Epirubicin—testicular cancer	0.00016	0.000933	CcSEcCtD
Melatonin—Dyspepsia—Epirubicin—testicular cancer	0.000159	0.000924	CcSEcCtD
Melatonin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000158	0.000917	CcSEcCtD
Melatonin—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000156	0.000906	CcSEcCtD
Melatonin—Fatigue—Epirubicin—testicular cancer	0.000156	0.000905	CcSEcCtD
Melatonin—Pain—Epirubicin—testicular cancer	0.000154	0.000898	CcSEcCtD
Melatonin—Abdominal pain—Methotrexate—testicular cancer	0.000152	0.000887	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000152	0.000885	CcSEcCtD
Melatonin—Insomnia—Doxorubicin—testicular cancer	0.000151	0.000879	CcSEcCtD
Melatonin—Paraesthesia—Doxorubicin—testicular cancer	0.00015	0.000872	CcSEcCtD
Melatonin—Somnolence—Doxorubicin—testicular cancer	0.000148	0.000864	CcSEcCtD
Melatonin—Gastrointestinal pain—Epirubicin—testicular cancer	0.000147	0.000858	CcSEcCtD
Melatonin—Dyspepsia—Doxorubicin—testicular cancer	0.000147	0.000855	CcSEcCtD
Melatonin—ESR1—Signaling by ERBB4—KIT—testicular cancer	0.000147	0.00254	CbGpPWpGaD
Melatonin—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000144	0.000839	CcSEcCtD
Melatonin—Fatigue—Doxorubicin—testicular cancer	0.000144	0.000837	CcSEcCtD
Melatonin—CALM3—Downstream signal transduction—KITLG—testicular cancer	0.000143	0.00248	CbGpPWpGaD
Melatonin—CYP2C9—Biological oxidations—HPGDS—testicular cancer	0.000143	0.00248	CbGpPWpGaD
Melatonin—Pain—Doxorubicin—testicular cancer	0.000143	0.000831	CcSEcCtD
Melatonin—Abdominal pain—Epirubicin—testicular cancer	0.000143	0.00083	CcSEcCtD
Melatonin—CALM3—Signaling by FGFR—KITLG—testicular cancer	0.000143	0.00247	CbGpPWpGaD
Melatonin—Hypersensitivity—Methotrexate—testicular cancer	0.000142	0.000826	CcSEcCtD
Melatonin—CALM3—Signaling by ERBB2—KITLG—testicular cancer	0.000142	0.00246	CbGpPWpGaD
Melatonin—CALM3—DAP12 signaling—KITLG—testicular cancer	0.000141	0.00245	CbGpPWpGaD
Melatonin—CALM1—Downstream signal transduction—KITLG—testicular cancer	0.000139	0.0024	CbGpPWpGaD
Melatonin—CALM2—Downstream signal transduction—KITLG—testicular cancer	0.000139	0.0024	CbGpPWpGaD
Melatonin—Asthenia—Methotrexate—testicular cancer	0.000138	0.000805	CcSEcCtD
Melatonin—CALM1—Signaling by FGFR—KITLG—testicular cancer	0.000138	0.00239	CbGpPWpGaD
Melatonin—CALM2—Signaling by FGFR—KITLG—testicular cancer	0.000138	0.00239	CbGpPWpGaD
Melatonin—CALM1—Signaling by ERBB2—KITLG—testicular cancer	0.000137	0.00238	CbGpPWpGaD
Melatonin—CALM2—Signaling by ERBB2—KITLG—testicular cancer	0.000137	0.00238	CbGpPWpGaD
Melatonin—CALM1—DAP12 signaling—KITLG—testicular cancer	0.000137	0.00237	CbGpPWpGaD
Melatonin—CALM2—DAP12 signaling—KITLG—testicular cancer	0.000137	0.00237	CbGpPWpGaD
Melatonin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000136	0.000794	CcSEcCtD
Melatonin—Pruritus—Methotrexate—testicular cancer	0.000136	0.000794	CcSEcCtD
Melatonin—ESR1—Gene Expression—DNMT3L—testicular cancer	0.000133	0.0023	CbGpPWpGaD
Melatonin—Hypersensitivity—Epirubicin—testicular cancer	0.000133	0.000773	CcSEcCtD
Melatonin—CALM3—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.000133	0.0023	CbGpPWpGaD
Melatonin—CALM3—DAP12 interactions—KITLG—testicular cancer	0.000133	0.0023	CbGpPWpGaD
Melatonin—CALM3—Signaling by FGFR in disease—KITLG—testicular cancer	0.000133	0.0023	CbGpPWpGaD
Melatonin—Abdominal pain—Doxorubicin—testicular cancer	0.000132	0.000768	CcSEcCtD
Melatonin—CALM3—Signaling by EGFR—KITLG—testicular cancer	0.000132	0.00228	CbGpPWpGaD
Melatonin—CALM3—Signaling by EGFR in Cancer—KITLG—testicular cancer	0.00013	0.00226	CbGpPWpGaD
Melatonin—CALM3—Signaling by PDGF—KITLG—testicular cancer	0.00013	0.00225	CbGpPWpGaD
Melatonin—Asthenia—Epirubicin—testicular cancer	0.000129	0.000753	CcSEcCtD
Melatonin—CALM1—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.000128	0.00223	CbGpPWpGaD
Melatonin—CALM1—Signaling by FGFR in disease—KITLG—testicular cancer	0.000128	0.00223	CbGpPWpGaD
Melatonin—CALM2—Signaling by FGFR in disease—KITLG—testicular cancer	0.000128	0.00223	CbGpPWpGaD
Melatonin—CALM2—Fc epsilon receptor (FCERI) signaling—KITLG—testicular cancer	0.000128	0.00223	CbGpPWpGaD
Melatonin—CALM2—DAP12 interactions—KITLG—testicular cancer	0.000128	0.00223	CbGpPWpGaD
Melatonin—CALM1—DAP12 interactions—KITLG—testicular cancer	0.000128	0.00223	CbGpPWpGaD
Melatonin—Pruritus—Epirubicin—testicular cancer	0.000128	0.000743	CcSEcCtD
Melatonin—Dizziness—Methotrexate—testicular cancer	0.000127	0.000742	CcSEcCtD
Melatonin—CALM1—Signaling by EGFR—KITLG—testicular cancer	0.000127	0.00221	CbGpPWpGaD
Melatonin—CALM2—Signaling by EGFR—KITLG—testicular cancer	0.000127	0.00221	CbGpPWpGaD
Melatonin—CALR—Immune System—FGFR3—testicular cancer	0.000127	0.0022	CbGpPWpGaD
Melatonin—CALM2—Signaling by EGFR in Cancer—KITLG—testicular cancer	0.000126	0.00219	CbGpPWpGaD
Melatonin—CALM1—Signaling by EGFR in Cancer—KITLG—testicular cancer	0.000126	0.00219	CbGpPWpGaD
Melatonin—CALM1—Signaling by PDGF—KITLG—testicular cancer	0.000126	0.00218	CbGpPWpGaD
Melatonin—CALM2—Signaling by PDGF—KITLG—testicular cancer	0.000126	0.00218	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000124	0.00215	CbGpPWpGaD
Melatonin—Hypersensitivity—Doxorubicin—testicular cancer	0.000123	0.000716	CcSEcCtD
Melatonin—CALM3—B Cell Activation—KITLG—testicular cancer	0.000123	0.00213	CbGpPWpGaD
Melatonin—Vomiting—Methotrexate—testicular cancer	0.000123	0.000713	CcSEcCtD
Melatonin—CYP1A2—Biological oxidations—HPGDS—testicular cancer	0.000122	0.00212	CbGpPWpGaD
Melatonin—Rash—Methotrexate—testicular cancer	0.000122	0.000707	CcSEcCtD
Melatonin—Dermatitis—Methotrexate—testicular cancer	0.000121	0.000707	CcSEcCtD
Melatonin—Headache—Methotrexate—testicular cancer	0.000121	0.000703	CcSEcCtD
Melatonin—Asthenia—Doxorubicin—testicular cancer	0.00012	0.000697	CcSEcCtD
Melatonin—CYP1B1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.00012	0.00207	CbGpPWpGaD
Melatonin—Dizziness—Epirubicin—testicular cancer	0.000119	0.000694	CcSEcCtD
Melatonin—CALM1—B Cell Activation—KITLG—testicular cancer	0.000119	0.00206	CbGpPWpGaD
Melatonin—CALM2—B Cell Activation—KITLG—testicular cancer	0.000119	0.00206	CbGpPWpGaD
Melatonin—CALM3—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	0.000118	0.00205	CbGpPWpGaD
Melatonin—Pruritus—Doxorubicin—testicular cancer	0.000118	0.000687	CcSEcCtD
Melatonin—CALM3—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.000118	0.00204	CbGpPWpGaD
Melatonin—CALR—Disease—FGFR3—testicular cancer	0.000117	0.00203	CbGpPWpGaD
Melatonin—CALR—Immune System—KIT—testicular cancer	0.000116	0.00202	CbGpPWpGaD
Melatonin—Vomiting—Epirubicin—testicular cancer	0.000115	0.000667	CcSEcCtD
Melatonin—Nausea—Methotrexate—testicular cancer	0.000114	0.000666	CcSEcCtD
Melatonin—CALM2—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	0.000114	0.00198	CbGpPWpGaD
Melatonin—CALM1—RNF mutants show enhanced WNT signaling and proliferation—H2AFZ—testicular cancer	0.000114	0.00198	CbGpPWpGaD
Melatonin—CALM2—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.000114	0.00197	CbGpPWpGaD
Melatonin—CALM1—NGF signalling via TRKA from the plasma membrane—KITLG—testicular cancer	0.000114	0.00197	CbGpPWpGaD
Melatonin—Rash—Epirubicin—testicular cancer	0.000114	0.000662	CcSEcCtD
Melatonin—Dermatitis—Epirubicin—testicular cancer	0.000114	0.000661	CcSEcCtD
Melatonin—CALM3—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.000113	0.00196	CbGpPWpGaD
Melatonin—Headache—Epirubicin—testicular cancer	0.000113	0.000658	CcSEcCtD
Melatonin—MTNR1A—Signaling Pathways—H2AFZ—testicular cancer	0.000112	0.00195	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—H2AFZ—testicular cancer	0.000112	0.00195	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—STK11—testicular cancer	0.000112	0.00194	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—STK11—testicular cancer	0.000112	0.00194	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—INSL3—testicular cancer	0.000112	0.00194	CbGpPWpGaD
Melatonin—Dizziness—Doxorubicin—testicular cancer	0.00011	0.000642	CcSEcCtD
Melatonin—CALM3—Signaling by WNT in cancer—H2AFZ—testicular cancer	0.00011	0.0019	CbGpPWpGaD
Melatonin—CALM1—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.00011	0.0019	CbGpPWpGaD
Melatonin—CALM2—Downstream signaling of activated FGFR—FGFR3—testicular cancer	0.00011	0.0019	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—INSL3—testicular cancer	0.000108	0.00187	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—INSL3—testicular cancer	0.000108	0.00187	CbGpPWpGaD
Melatonin—CALR—Disease—KIT—testicular cancer	0.000108	0.00186	CbGpPWpGaD
Melatonin—Nausea—Epirubicin—testicular cancer	0.000107	0.000624	CcSEcCtD
Melatonin—CALM3—Downstream signal transduction—FGFR3—testicular cancer	0.000106	0.00185	CbGpPWpGaD
Melatonin—CALM2—Signaling by WNT in cancer—H2AFZ—testicular cancer	0.000106	0.00184	CbGpPWpGaD
Melatonin—CALM1—Signaling by WNT in cancer—H2AFZ—testicular cancer	0.000106	0.00184	CbGpPWpGaD
Melatonin—Vomiting—Doxorubicin—testicular cancer	0.000106	0.000618	CcSEcCtD
Melatonin—CALM3—Signaling by FGFR—FGFR3—testicular cancer	0.000106	0.00184	CbGpPWpGaD
Melatonin—CALM3—Signaling by ERBB2—FGFR3—testicular cancer	0.000105	0.00183	CbGpPWpGaD
Melatonin—Rash—Doxorubicin—testicular cancer	0.000105	0.000612	CcSEcCtD
Melatonin—Dermatitis—Doxorubicin—testicular cancer	0.000105	0.000612	CcSEcCtD
Melatonin—CALM3—DAP12 signaling—FGFR3—testicular cancer	0.000105	0.00182	CbGpPWpGaD
Melatonin—Headache—Doxorubicin—testicular cancer	0.000105	0.000609	CcSEcCtD
Melatonin—CALM3—Downstream signaling of activated FGFR—KIT—testicular cancer	0.000104	0.0018	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—KITLG—testicular cancer	0.000103	0.00179	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—KITLG—testicular cancer	0.000103	0.00179	CbGpPWpGaD
Melatonin—CALM2—Downstream signal transduction—FGFR3—testicular cancer	0.000103	0.00179	CbGpPWpGaD
Melatonin—CALM1—Downstream signal transduction—FGFR3—testicular cancer	0.000103	0.00179	CbGpPWpGaD
Melatonin—CALM2—Signaling by FGFR—FGFR3—testicular cancer	0.000102	0.00178	CbGpPWpGaD
Melatonin—CALM1—Signaling by FGFR—FGFR3—testicular cancer	0.000102	0.00178	CbGpPWpGaD
Melatonin—CALM2—Signaling by ERBB2—FGFR3—testicular cancer	0.000102	0.00177	CbGpPWpGaD
Melatonin—CALM1—Signaling by ERBB2—FGFR3—testicular cancer	0.000102	0.00177	CbGpPWpGaD
Melatonin—CALM1—DAP12 signaling—FGFR3—testicular cancer	0.000101	0.00176	CbGpPWpGaD
Melatonin—CALM2—DAP12 signaling—FGFR3—testicular cancer	0.000101	0.00176	CbGpPWpGaD
Melatonin—CALM2—Downstream signaling of activated FGFR—KIT—testicular cancer	0.000101	0.00174	CbGpPWpGaD
Melatonin—CALM1—Downstream signaling of activated FGFR—KIT—testicular cancer	0.000101	0.00174	CbGpPWpGaD
Melatonin—Nausea—Doxorubicin—testicular cancer	9.91e-05	0.000577	CcSEcCtD
Melatonin—CALM3—Signaling by FGFR in disease—FGFR3—testicular cancer	9.87e-05	0.00171	CbGpPWpGaD
Melatonin—CALM3—DAP12 interactions—FGFR3—testicular cancer	9.87e-05	0.00171	CbGpPWpGaD
Melatonin—CALM3—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	9.87e-05	0.00171	CbGpPWpGaD
Melatonin—CALM3—Signaling by EGFR—FGFR3—testicular cancer	9.78e-05	0.0017	CbGpPWpGaD
Melatonin—CALM3—Downstream signal transduction—KIT—testicular cancer	9.77e-05	0.00169	CbGpPWpGaD
Melatonin—CALM3—Signaling by FGFR—KIT—testicular cancer	9.73e-05	0.00169	CbGpPWpGaD
Melatonin—CALM3—Signaling by EGFR in Cancer—FGFR3—testicular cancer	9.69e-05	0.00168	CbGpPWpGaD
Melatonin—CALM3—Signaling by ERBB2—KIT—testicular cancer	9.68e-05	0.00168	CbGpPWpGaD
Melatonin—CALM3—Signaling by PDGF—FGFR3—testicular cancer	9.65e-05	0.00167	CbGpPWpGaD
Melatonin—CALM3—DAP12 signaling—KIT—testicular cancer	9.63e-05	0.00167	CbGpPWpGaD
Melatonin—CALM1—DAP12 interactions—FGFR3—testicular cancer	9.55e-05	0.00165	CbGpPWpGaD
Melatonin—CALM1—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	9.55e-05	0.00165	CbGpPWpGaD
Melatonin—CALM2—Signaling by FGFR in disease—FGFR3—testicular cancer	9.55e-05	0.00165	CbGpPWpGaD
Melatonin—CALM2—Fc epsilon receptor (FCERI) signaling—FGFR3—testicular cancer	9.55e-05	0.00165	CbGpPWpGaD
Melatonin—CALM1—Signaling by FGFR in disease—FGFR3—testicular cancer	9.55e-05	0.00165	CbGpPWpGaD
Melatonin—CALM2—DAP12 interactions—FGFR3—testicular cancer	9.55e-05	0.00165	CbGpPWpGaD
Melatonin—CALM1—Signaling by EGFR—FGFR3—testicular cancer	9.46e-05	0.00164	CbGpPWpGaD
Melatonin—CALM2—Signaling by EGFR—FGFR3—testicular cancer	9.46e-05	0.00164	CbGpPWpGaD
Melatonin—CALM2—Downstream signal transduction—KIT—testicular cancer	9.45e-05	0.00164	CbGpPWpGaD
Melatonin—CALM1—Downstream signal transduction—KIT—testicular cancer	9.45e-05	0.00164	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—INSL3—testicular cancer	9.45e-05	0.00164	CbGpPWpGaD
Melatonin—CALM1—Signaling by FGFR—KIT—testicular cancer	9.41e-05	0.00163	CbGpPWpGaD
Melatonin—CALM2—Signaling by FGFR—KIT—testicular cancer	9.41e-05	0.00163	CbGpPWpGaD
Melatonin—CALM1—Signaling by EGFR in Cancer—FGFR3—testicular cancer	9.38e-05	0.00163	CbGpPWpGaD
Melatonin—CALM2—Signaling by EGFR in Cancer—FGFR3—testicular cancer	9.38e-05	0.00163	CbGpPWpGaD
Melatonin—CALM2—Signaling by ERBB2—KIT—testicular cancer	9.36e-05	0.00162	CbGpPWpGaD
Melatonin—CALM1—Signaling by ERBB2—KIT—testicular cancer	9.36e-05	0.00162	CbGpPWpGaD
Melatonin—CALM2—Signaling by PDGF—FGFR3—testicular cancer	9.34e-05	0.00162	CbGpPWpGaD
Melatonin—CALM1—Signaling by PDGF—FGFR3—testicular cancer	9.34e-05	0.00162	CbGpPWpGaD
Melatonin—CALM2—DAP12 signaling—KIT—testicular cancer	9.32e-05	0.00161	CbGpPWpGaD
Melatonin—CALM1—DAP12 signaling—KIT—testicular cancer	9.32e-05	0.00161	CbGpPWpGaD
Melatonin—CALM3—B Cell Activation—FGFR3—testicular cancer	9.13e-05	0.00158	CbGpPWpGaD
Melatonin—CALM3—DAP12 interactions—KIT—testicular cancer	9.06e-05	0.00157	CbGpPWpGaD
Melatonin—CALM3—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	9.06e-05	0.00157	CbGpPWpGaD
Melatonin—CALM3—Signaling by FGFR in disease—KIT—testicular cancer	9.06e-05	0.00157	CbGpPWpGaD
Melatonin—CALM3—Signaling by Wnt—H2AFZ—testicular cancer	9.06e-05	0.00157	CbGpPWpGaD
Melatonin—CALM3—Signaling by NGF—KITLG—testicular cancer	9.05e-05	0.00157	CbGpPWpGaD
Melatonin—CALM3—Signaling by EGFR—KIT—testicular cancer	8.98e-05	0.00156	CbGpPWpGaD
Melatonin—CALM3—Signaling by EGFR in Cancer—KIT—testicular cancer	8.9e-05	0.00154	CbGpPWpGaD
Melatonin—CALM3—Signaling by PDGF—KIT—testicular cancer	8.86e-05	0.00154	CbGpPWpGaD
Melatonin—CALM1—B Cell Activation—FGFR3—testicular cancer	8.83e-05	0.00153	CbGpPWpGaD
Melatonin—CALM2—B Cell Activation—FGFR3—testicular cancer	8.83e-05	0.00153	CbGpPWpGaD
Melatonin—CALM2—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	8.76e-05	0.00152	CbGpPWpGaD
Melatonin—CALM1—DAP12 interactions—KIT—testicular cancer	8.76e-05	0.00152	CbGpPWpGaD
Melatonin—CALM1—Fc epsilon receptor (FCERI) signaling—KIT—testicular cancer	8.76e-05	0.00152	CbGpPWpGaD
Melatonin—CALM2—DAP12 interactions—KIT—testicular cancer	8.76e-05	0.00152	CbGpPWpGaD
Melatonin—CALM2—Signaling by FGFR in disease—KIT—testicular cancer	8.76e-05	0.00152	CbGpPWpGaD
Melatonin—CALM1—Signaling by FGFR in disease—KIT—testicular cancer	8.76e-05	0.00152	CbGpPWpGaD
Melatonin—CALM2—Signaling by Wnt—H2AFZ—testicular cancer	8.76e-05	0.00152	CbGpPWpGaD
Melatonin—CALM1—Signaling by Wnt—H2AFZ—testicular cancer	8.76e-05	0.00152	CbGpPWpGaD
Melatonin—CALM2—Signaling by NGF—KITLG—testicular cancer	8.75e-05	0.00152	CbGpPWpGaD
Melatonin—CALM1—Signaling by NGF—KITLG—testicular cancer	8.75e-05	0.00152	CbGpPWpGaD
Melatonin—CALM3—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	8.74e-05	0.00152	CbGpPWpGaD
Melatonin—CALM2—Signaling by EGFR—KIT—testicular cancer	8.69e-05	0.00151	CbGpPWpGaD
Melatonin—CALM1—Signaling by EGFR—KIT—testicular cancer	8.69e-05	0.00151	CbGpPWpGaD
Melatonin—CALM2—Signaling by EGFR in Cancer—KIT—testicular cancer	8.61e-05	0.00149	CbGpPWpGaD
Melatonin—CALM1—Signaling by EGFR in Cancer—KIT—testicular cancer	8.61e-05	0.00149	CbGpPWpGaD
Melatonin—CALM1—Signaling by PDGF—KIT—testicular cancer	8.57e-05	0.00149	CbGpPWpGaD
Melatonin—CALM2—Signaling by PDGF—KIT—testicular cancer	8.57e-05	0.00149	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—BCL10—testicular cancer	8.56e-05	0.00148	CbGpPWpGaD
Melatonin—CALM2—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	8.46e-05	0.00147	CbGpPWpGaD
Melatonin—CALM1—NGF signalling via TRKA from the plasma membrane—FGFR3—testicular cancer	8.46e-05	0.00147	CbGpPWpGaD
Melatonin—CALM3—B Cell Activation—KIT—testicular cancer	8.38e-05	0.00145	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—BCL10—testicular cancer	8.28e-05	0.00143	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—BCL10—testicular cancer	8.28e-05	0.00143	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—BCL10—testicular cancer	8.22e-05	0.00142	CbGpPWpGaD
Melatonin—CALM1—B Cell Activation—KIT—testicular cancer	8.11e-05	0.00141	CbGpPWpGaD
Melatonin—CALM2—B Cell Activation—KIT—testicular cancer	8.11e-05	0.00141	CbGpPWpGaD
Melatonin—CALM3—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	8.02e-05	0.00139	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—BCL10—testicular cancer	7.95e-05	0.00138	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—BCL10—testicular cancer	7.95e-05	0.00138	CbGpPWpGaD
Melatonin—CALM1—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	7.76e-05	0.00135	CbGpPWpGaD
Melatonin—CALM2—NGF signalling via TRKA from the plasma membrane—KIT—testicular cancer	7.76e-05	0.00135	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—FGFR3—testicular cancer	7.69e-05	0.00133	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—FGFR3—testicular cancer	7.69e-05	0.00133	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	7.36e-05	0.00128	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—KIT—testicular cancer	7.06e-05	0.00122	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—KIT—testicular cancer	7.06e-05	0.00122	CbGpPWpGaD
Melatonin—CALM3—Signaling by NGF—FGFR3—testicular cancer	6.72e-05	0.00117	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—INSL3—testicular cancer	6.6e-05	0.00114	CbGpPWpGaD
Melatonin—CALM2—Signaling by NGF—FGFR3—testicular cancer	6.5e-05	0.00113	CbGpPWpGaD
Melatonin—CALM1—Signaling by NGF—FGFR3—testicular cancer	6.5e-05	0.00113	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—INSL3—testicular cancer	6.38e-05	0.00111	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—INSL3—testicular cancer	6.38e-05	0.00111	CbGpPWpGaD
Melatonin—CALM3—Signaling by NGF—KIT—testicular cancer	6.17e-05	0.00107	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	6.03e-05	0.00104	CbGpPWpGaD
Melatonin—CALM1—Signaling by NGF—KIT—testicular cancer	5.97e-05	0.00103	CbGpPWpGaD
Melatonin—CALM2—Signaling by NGF—KIT—testicular cancer	5.97e-05	0.00103	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—HPGDS—testicular cancer	5.53e-05	0.000958	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	5.49e-05	0.000952	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—HPGDS—testicular cancer	5.32e-05	0.000923	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—KITLG—testicular cancer	5.16e-05	0.000894	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—KITLG—testicular cancer	4.99e-05	0.000865	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—KITLG—testicular cancer	4.99e-05	0.000865	CbGpPWpGaD
Melatonin—CALM3—Immune System—BCL10—testicular cancer	4.98e-05	0.000864	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—KITLG—testicular cancer	4.95e-05	0.000859	CbGpPWpGaD
Melatonin—CALM1—Immune System—BCL10—testicular cancer	4.82e-05	0.000836	CbGpPWpGaD
Melatonin—CALM2—Immune System—BCL10—testicular cancer	4.82e-05	0.000836	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—KITLG—testicular cancer	4.79e-05	0.000831	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—KITLG—testicular cancer	4.79e-05	0.000831	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	4.69e-05	0.000814	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—H2AFZ—testicular cancer	4.65e-05	0.000806	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—STK11—testicular cancer	4.02e-05	0.000696	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—STK11—testicular cancer	3.87e-05	0.000671	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—FGFR3—testicular cancer	3.83e-05	0.000665	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—FGFR3—testicular cancer	3.71e-05	0.000643	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—FGFR3—testicular cancer	3.71e-05	0.000643	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—FGFR3—testicular cancer	3.68e-05	0.000638	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—FGFR3—testicular cancer	3.56e-05	0.000617	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—FGFR3—testicular cancer	3.56e-05	0.000617	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—KIT—testicular cancer	3.52e-05	0.00061	CbGpPWpGaD
Melatonin—CALM3—Metabolism—HPGDS—testicular cancer	3.46e-05	0.000599	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—KIT—testicular cancer	3.41e-05	0.00059	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—KIT—testicular cancer	3.41e-05	0.00059	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—KIT—testicular cancer	3.38e-05	0.000586	CbGpPWpGaD
Melatonin—CALM2—Metabolism—HPGDS—testicular cancer	3.34e-05	0.000579	CbGpPWpGaD
Melatonin—CALM1—Metabolism—HPGDS—testicular cancer	3.34e-05	0.000579	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—HPGDS—testicular cancer	3.28e-05	0.000568	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—KIT—testicular cancer	3.27e-05	0.000567	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—KIT—testicular cancer	3.27e-05	0.000567	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—H2AFZ—testicular cancer	3.02e-05	0.000524	CbGpPWpGaD
Melatonin—CALM3—Disease—H2AFZ—testicular cancer	3.02e-05	0.000523	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—STK11—testicular cancer	3.01e-05	0.000521	CbGpPWpGaD
Melatonin—CALM3—Immune System—KITLG—testicular cancer	3e-05	0.000521	CbGpPWpGaD
Melatonin—CALM2—Disease—H2AFZ—testicular cancer	2.92e-05	0.000506	CbGpPWpGaD
Melatonin—CALM1—Disease—H2AFZ—testicular cancer	2.92e-05	0.000506	CbGpPWpGaD
Melatonin—CALM2—Immune System—KITLG—testicular cancer	2.91e-05	0.000504	CbGpPWpGaD
Melatonin—CALM1—Immune System—KITLG—testicular cancer	2.91e-05	0.000504	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—KITLG—testicular cancer	2.78e-05	0.000482	CbGpPWpGaD
Melatonin—CALM3—Disease—KITLG—testicular cancer	2.77e-05	0.000481	CbGpPWpGaD
Melatonin—CALM1—Disease—KITLG—testicular cancer	2.68e-05	0.000465	CbGpPWpGaD
Melatonin—CALM2—Disease—KITLG—testicular cancer	2.68e-05	0.000465	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—HPGDS—testicular cancer	2.68e-05	0.000465	CbGpPWpGaD
Melatonin—CALM3—Metabolism—STK11—testicular cancer	2.51e-05	0.000435	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—HPGDS—testicular cancer	2.45e-05	0.000424	CbGpPWpGaD
Melatonin—CALM2—Metabolism—STK11—testicular cancer	2.43e-05	0.000421	CbGpPWpGaD
Melatonin—CALM1—Metabolism—STK11—testicular cancer	2.43e-05	0.000421	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—STK11—testicular cancer	2.38e-05	0.000413	CbGpPWpGaD
Melatonin—CALM3—Immune System—FGFR3—testicular cancer	2.23e-05	0.000387	CbGpPWpGaD
Melatonin—CALM1—Immune System—FGFR3—testicular cancer	2.16e-05	0.000374	CbGpPWpGaD
Melatonin—CALM2—Immune System—FGFR3—testicular cancer	2.16e-05	0.000374	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—H2AFZ—testicular cancer	2.11e-05	0.000366	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—STK11—testicular cancer	2.1e-05	0.000364	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—HPGDS—testicular cancer	2.09e-05	0.000362	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—FGFR3—testicular cancer	2.07e-05	0.000359	CbGpPWpGaD
Melatonin—CALM3—Disease—FGFR3—testicular cancer	2.06e-05	0.000357	CbGpPWpGaD
Melatonin—CALM3—Immune System—KIT—testicular cancer	2.05e-05	0.000355	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—H2AFZ—testicular cancer	2.04e-05	0.000354	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—H2AFZ—testicular cancer	2.04e-05	0.000354	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—STK11—testicular cancer	2.03e-05	0.000352	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—STK11—testicular cancer	2.03e-05	0.000352	CbGpPWpGaD
Melatonin—CALM2—Disease—FGFR3—testicular cancer	1.99e-05	0.000346	CbGpPWpGaD
Melatonin—CALM1—Disease—FGFR3—testicular cancer	1.99e-05	0.000346	CbGpPWpGaD
Melatonin—CALM1—Immune System—KIT—testicular cancer	1.98e-05	0.000344	CbGpPWpGaD
Melatonin—CALM2—Immune System—KIT—testicular cancer	1.98e-05	0.000344	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—STK11—testicular cancer	1.95e-05	0.000338	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—KITLG—testicular cancer	1.94e-05	0.000337	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—KIT—testicular cancer	1.9e-05	0.000329	CbGpPWpGaD
Melatonin—CALM3—Disease—KIT—testicular cancer	1.89e-05	0.000328	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KITLG—testicular cancer	1.88e-05	0.000326	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KITLG—testicular cancer	1.88e-05	0.000326	CbGpPWpGaD
Melatonin—CALM2—Disease—KIT—testicular cancer	1.83e-05	0.000317	CbGpPWpGaD
Melatonin—CALM1—Disease—KIT—testicular cancer	1.83e-05	0.000317	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—STK11—testicular cancer	1.78e-05	0.000308	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—STK11—testicular cancer	1.52e-05	0.000263	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—FGFR3—testicular cancer	1.44e-05	0.00025	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—FGFR3—testicular cancer	1.4e-05	0.000242	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—FGFR3—testicular cancer	1.4e-05	0.000242	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—KIT—testicular cancer	1.33e-05	0.00023	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KIT—testicular cancer	1.28e-05	0.000222	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KIT—testicular cancer	1.28e-05	0.000222	CbGpPWpGaD
